Yao-Chun Hsu (Y-C Hsu, Yao Chun Hsu)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Antiretroviral Therapy

Hepatitis B Virus

Total Hip Arthroplasty

Top Venues

Alimentary pharmacology & therapeutics

Hepatology (Baltimore, Md.)

Journal of viral hepatitis

Clinical liver disease

This page only lists publications with an associated author ORCID identifier.

Publications

Loey Lung-Yi Mak, Leland J Yee, Robert J Wong, Christian B Ramers, Catherine Frenette, Yao-Chun Hsu
Hepatocellular carcinoma among patients with chronic hepatitis B in the indeterminate phase. Journal of viral hepatitis (2024)
Loey Lung-Yi Mak, Ken Liu, Sakkarin Chirapongsathorn, Kuo Chao Yew, Nobuharu Tamaki, Ruveena Bhavani Rajaram, Mara Teresa T Panlilio, Rashid Nok-Shun Lui, Hye-Won Lee, Jimmy Che To Lai, Anand V Kulkarni, Madhumita Premkumar, Cosmas Rinaldi Adithya Lesmana, Yao-Chun Hsu, Daniel Q Huang
Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions. Nature reviews. Gastroenterology & hepatology (2024)
Yao-Chun Hsu
Finite therapy of chronic hepatitis B infection: Cons. Clinical liver disease 23 (1) (2024)
Yao-Chun Hsu
Finite therapy of chronic hepatitis B infection: Cons. Clinical liver disease 23 (1) (2024)
Yao-Chun Hsu, Chun-Ying Wu
Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation-Insights from a real-world study. Authors' reply. Alimentary pharmacology & therapeutics 58 (5) (2023)
Yao-Chun Hsu, Daniel Q Huang, Mindie H Nguyen
Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nature reviews. Gastroenterology & hepatology (2023)
Yao-Chun Hsu, Mindie H Nguyen, Chun-Ying Wu
Letter: Safety after cessation of nucleos(t)ide analogue therapy in patients with chronic hepatitis B infection-Authors' reply. Alimentary pharmacology & therapeutics 58 (7) (2023)
Yao-Chun Hsu, Yi-Hsian Lin, Teng-Yu Lee, Mindie H Nguyen, Cheng-Hao Tseng, Hsiu J Ho, Feng-Yu Kao, Jaw-Town Lin, Chen-Yi Wu, Chun-Ying Wu
Severe hepatitis B flares with hepatic decompensation after withdrawal of nucleos(t)ide analogues: A population-based cohort study. Alimentary pharmacology & therapeutics (2023)
Jacki Chen, Thomas Tu, Chari Cohen, Su Wang, Yao-Chun Hsu, Robert G Gish
Letter to the Editor: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game? Hepatology (Baltimore, Md.) 79 (5) (2023)
Jacki Chen, Thomas Tu, Chari Cohen, Su Wang, Yao-Chun Hsu, Robert G Gish
Letter to the Editor: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game? Hepatology (Baltimore, Md.) 79 (5) (2023)
Jacki Chen, Thomas Tu, Chari Cohen, Su Wang, Yao-Chun Hsu, Robert G Gish
Letter to the Editor: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game? Hepatology (Baltimore, Md.) (2023)
Yao-Chun Hsu, Cheng-Hao Tseng, Tung-Hung Su, Jia-Horng Kao, Mindie H Nguyen
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities. Gut (2021)
Yao-Chun Hsu, Yen-Tsung Huang
Editorial: risk assessment for chronic hepatitis B patients in the immune tolerant phase-both definition and selection matter. Alimentary pharmacology & therapeutics 52 (1) (2020)
Cheng-Hao Tseng, Mindie H Nguyen, Yao-Chun Hsu
Is tenofovir more effective than entecavir to prevent hepatocellular carcinoma? The controversy goes on. Hepatology international 14 (5) (2020)
Chien-Hung Chen, Yao-Chun Hsu, S-N Lu, C-H Hung, J-H Wang, C-M Lee, Tsung-Hui Hu
The incidence and predictors of HBV relapse after cessation of tenofovir therapy in chronic hepatitis B patients. Journal of viral hepatitis 25 (5) (2018)
Yao-Chun Hsu, Tomi Jun, Yen-Tsung Huang, Ming-Lun Yeh, Chia-Long Lee, Shintaro Ogawa, Shu-Hsien Cho, Jaw-Town Lin, Ming-Lung Yu, Mindie H Nguyen, Yasuhito Tanaka
Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 48 (10) (2018)
Feng-Chen Kao, Yao-Chun Hsu, Chang-Bi Wang, Yuan-Kun Tu, Pao-Hsin Liu
Short-term and long-term revision rates after lumbar spine discectomy versus laminectomy: a population-based cohort study. BMJ open 8 (7) (2018)
Yao-Chun Hsu, Hsiu-J Ho, Teng-Yu Lee, Yen-Tsung Huang, Ming-Shiang Wu, Jaw-Town Lin, Chun-Ying Wu, Hashem B El-Serag
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir. Journal of viral hepatitis 25 (5) (2018)
Yao-Chun Hsu, Mindie H Nguyen, Lein-Ray Mo, Ming-Shiang Wu, Tzeng-Huey Yang, Chieh-Chang Chen, Cheng-Hao Tseng, Chi-Ming Tai, Chun-Ying Wu, Jaw-Town Lin, Yasuhito Tanaka, Chi-Yang Chang
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk. Alimentary pharmacology & therapeutics 49 (1) (2018)